WeVote
Log In

Bill

Bill

HB 1381

Experimental Treatments for Terminal Conditions and Life-threatening Rare Diseases

2026 Regular Session Introduced by Gallop Franklin

HB 1381 expands Florida patient access to experimental treatments for terminal and rare diseases outside standard FDA approval pathways, prioritizing patient autonomy but creating safety and regulatory oversight concerns.

Now in Health Professions & Programs Subcommittee
#andsolicitations
0
WeVote Research Nonpartisan
Bill Summary · HB 1381

Legislative bill overview

HB 1381 would expand Florida patient access to experimental medical treatments for individuals with terminal conditions and life-threatening rare diseases outside of standard FDA approval pathways. The bill appears to establish a framework allowing eligible patients to pursue investigational therapies when conventional treatments have been exhausted or are ineffective.

Why is this important

Patients with terminal or rare diseases often face limited treatment options and may die before experimental therapies complete lengthy FDA approval processes. This bill addresses the tension between patient autonomy/hope and regulatory safety standards that typically require extensive clinical trials before drug availability.

Potential points of contention

  • Safety versus access tradeoff: Experimental treatments bypass standard safety testing, creating risk of harm, ineffective treatment, or exploitation of desperate patients seeking unproven cures
  • FDA regulatory authority: The bill may conflict with or circumvent federal drug approval processes, raising questions about state versus federal jurisdiction over medication safety
  • Patient vulnerability and informed consent: Terminally ill patients may lack capacity for truly voluntary consent and could be targeted by unscrupulous providers offering false hope at high cost
  • Data collection and transparency: Without FDA oversight, there may be limited mechanisms to track outcomes, adverse events, or real efficacy of experimental treatments

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.